Company: TEM
Filing Date: 2025-02-24
Form Type: 10-K
Source: 0000950170-25-025603
Chunk: 534

Company: Tempus AI, Inc.
Filing Date: 2025-02-24
Form: 10-K
Item: Item 1B
Chunk 534
---
 shares authorized at December 31, 2024 and December 31, 2023, respectively; no shares issued and outstanding at December 31, 2024, and 5,205,802 shares issued and 5,060,336 shares outstanding at December 31, 2023

    —

    0

    Treasury Stock, 145,466 shares at December 31, 2024 and December 31, 2023, at cost

    (3,602
    )

    (3,602
    )

    Additional Paid-In Capital

    2,210,664

    18,345

    Accumulated Other Comprehensive Income

    94

    5

    Accumulated deficit

    (2,150,834
    )

    (1,396,917
    )

    Total Stockholders' equity (deficit)
     
    $
    56,339

    $
    (1,382,163
    )

    Total Liabilities, Convertible redeemable preferred stock,   and Stockholders' equity (deficit)
     
    $
    926,116

    $
    564,052

The accompanying notes are an integral part of these consolidated financial statements.

140

Tempus AI, Inc. 

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS 

(in thousands, except per share amounts) 

    Year Ended December 31,

    2024

    2023

    2022

    Net revenue

    Genomics
    $
    451,749

    $
    363,022

    $
    197,984

    Data and services
     
    241,649

    168,800

    122,684

    Total net revenue
    $
    693,398

    $
    531,822

    $
    320,668

    Cost and operating expenses

    Cost of revenues, genomics
     
    243,467

    189,165

    150,255

    Cost of revenues, data and services
     
    68,818

    56,482

    40,227

    Technology research and development
     
    167,519

    95,155

    79,093

    Research and development
     
    149,325

    90,